- CONTACT
- Donna Krupa
- Office: 301.634.7209
- DKrupa@the-aps.org
Chromium Picolinate May Lessen Inflammation in Diabetic Nephropathy
Supplement linked to decreased protein in the urine of diabetic mice
Bethesda, Md. (September 22, 2010) – Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers at the Medical College of Georgia in Augusta. In a study comparing diabetic mice treated with chromium picolinate with those that received placebo, the researchers found that mice who received the supplement had lower levels of albuminuria (protein in the urine), an indication of kidney disease.
The Study
To arrive at their conclusions, the researchers compared three groups of mice, one lean, healthy group and two groups genetically engineered to be obese and have diabetes. When the mice were 6 weeks old, the researchers separated them according to treatment plan. The healthy mice and one group of diabetic mice, the untreated diabetic group, were fed a regular rodent diet. The remaining group, the treated diabetic group, were fed a diet enriched with chromium picolinate.
Over the course of 6 months, the researchers measured glycemic control and albuminuria in all three groups. The untreated diabetic mice excreted nearly 10 times more albumin than the db/m mice, which was to be expected. However, the treated diabetic mice, who were fed the diet with chromium picolinate, excreted about half as much albumin compared to their untreated diabetic counterparts.
At the end of 6 months, the mice were euthanized and the researchers studied tissue samples from the mice’s kidneys. They found that the untreated diabetic mice had marked immunostaining for interleukin 6 (IL-6) and interleukin 17 (IL-17), two cytokines associated with inflammation. These mice also had moderate immunostaining for indolamine 2,3-dioxygenase (IDO), an immunoregulatory enzyme that modulates the production of IL-6 and IL-17. However, the treated diabetic mice had intense immunostaining for IDO but reduced IL-6 and IL-17 compared to the untreated diabetic group. The implication is that the chromium picolinate may have reduced inflammation in the treated diabetic group by affecting IDO, IL-6, and IL-7.
Mahmood Mozaffari, DMD, PhD, professor in the Medical College of Georgia Department of Oral Biology and lead author of the study, noted that the results are preliminary and that further studies are necessary to tease out the effects of chromium picolinate. He is particularly interested in the relationship between IDO and chromium picolinate because IDO is involved in the metabolism of tryptophan, an amino acid, and one of the by-products of that metabolism is picolinic acid.
“This clearly raises an important question for us as to whether our observations are related to the provision of picolinic acid from the chromium picolinate or whether the formulation [chromium picolinate], in and of itself, is mediating the effects.”
###
NOTE TO EDITORS: Dr. Mozaffari discussed the study at the 2010 American Physiological Society conference, Inflammation, Immunity, and Cardiovascular Disease, in Westminster Colorado. To arrange an interview with him, please contact Donna Krupa at 301.634.7209 or dkrupa@the-aps.org.
Physiology is the study of how molecules, cells, tissues and organs function to create health or disease. The American Physiological Society (www.The-APS.org/press) has been an integral part of this discovery process since it was established in 1887.
Nicotine: The Link Between Cigarette Smoking and Kidney Disease Progression?
Released January 29, 2007 - Cigarette smoke is the most preventable cause of death and chronic disease in the United States. In addition to being a risk factor for cancer, recent epidemiologic studies suggest that cigarette smoke promotes the progression of kidney disease. The mechanisms by which cigarette smoke may accelerate some types of chronic kidney disease are currently unknown. A new study demonstrates for the first time that human mesangial cells (cells in the blood vessels of the kidneys) – are endowed with nicotinic receptors (cells that interact with the nicotine in tobacco) and may play an active role in the development of certain kidney diseases.
Female Gender Provides An Advantage In Renal Diseases
Released August 8, 2007 - Sex hormones (estrogen, testosterone) are thought to contribute to health differences, as hormones may influence the body’s responses to renal injury. Estrogen especially may exert certain cellular effects on the kidney because it can suppress the growth of scar tissue as well as affect various growth factors which impact the kidney.
Is Testosterone Replacement Therapy Safe For Aging Men?
Released August 8, 2007 - For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life. The increased use has occurred despite the fact that the cardiovascular effects of chronic testosterone treatment in aging males are largely unknown, and the safety of testosterone replacement has not been evaluated. Researchers are using an animal model to examine potential links between testosterone supplements, and cardiovascular and renal disease.
Estrogen Deficiency Can Lead To Obesity-Induced Hight BP After Menopause
Released August 8, 2007 - At menopause, women lose hormone protection against heart (cardiovascular) and kidney diseases, and are likely to become obese. A research team has tested the idea that estrogen deficiency in aged females may trigger the development of high blood pressure and obesity. The results of their study, using an animal model, suggest that estrogen depletion can have these effects.
The “Female Advantage” In Kidney Disease Doesn't Extend To Diabetic Women
Released August 8, 2007 - Women have a “female advantage” when it comes to chronic kidney disease. When compared to men, they have fewer and less severe episodes throughout most of their lives. That advantage disappears, however, when the woman is diabetic. For reasons still unclear, diabetic women are diagnosed with kidney and heart diseases almost as frequently as men. What is it about diabetes that predisposes a woman to develop renal disease at levels generally associated with her male counterpart? Researchers at Georgetown University’s Center for the Study of Sex Differences in Health, Aging and Disease have identified a novel observation to help explain why.